An antibody against phosphorylated neurofilaments identifies a subset of damaged association axons in Alzheimer's disease

Am J Pathol. 1993 Mar;142(3):871-82.

Abstract

We studied axonal damage in Alzheimer's disease frontal cortex and hippocampus with a novel monoclonal antibody (SMI 312) against phosphorylated neurofilaments. This antibody immunolabeled, with great detail, the neuropil axonal network. In aged normal cases only a few pyramidal cell perikarya were immunostained. In Alzheimer's disease there was a two- to four-fold increase in neuronal SMI 312 immunolabeling, and neuropil neuritic processes were severely disrupted. Double-immunolabeling analysis showed that 88% of SMI 312-immunolabeled abnormal neuritic clusters were associated with amyloid, whereas the remaining 12% were not. Serial section analysis and 3-D reconstructions suggested that dystrophic neurites of classical plaques were derived from long axons. These abnormal neurites were also growth-associated protein 43 positive and occasionally tau positive. The present study supports the contention that a subpopulation of aberrantly sprouting axons in the neuritic plaque is derived from cortico-cortico fibers. This disruption of the neocortical association fibers and neuritic microcircuitry could underlie the cognitive impairment of Alzheimer's disease.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / metabolism
  • Alzheimer Disease / pathology*
  • Antibodies, Monoclonal / immunology*
  • Axons / pathology*
  • Brain / metabolism
  • Brain / pathology*
  • Frontal Lobe / metabolism
  • Hippocampus / metabolism
  • Humans
  • Immunohistochemistry
  • Intermediate Filaments / immunology*
  • Intermediate Filaments / metabolism
  • Neurites / metabolism
  • Phosphorylation

Substances

  • Antibodies, Monoclonal